This HTML5 document contains 165 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34397557
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2014) 2014年论文 naučni članak מאמר מדעי artigo científico научни чланак مقالهٔ علمی научни чланак 2014年論文 2014年論文 επιστημονικό άρθρο artikull shkencor vitskapeleg artikkel 2014年の論文 vetenskaplig artikel artículo científico publicado en 2014 wissenschaftlicher Artikel 2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած 2014 nî lūn-bûn scientific article artykuł naukowy article científic 2014년 논문 articolo scientifico 2014年论文 teaduslik artikkel 2014 թվականի փետրվարին հրատարակված գիտական հոդված سائنسی مضمون научна статия სამეცნიერო სტატია bilimsel makale مقالة علمية tieteellinen artikkeli article scientific 2014年论文 2014年論文 мақолаи илмӣ บทความทางวิทยาศาสตร์ artikulong pang-agham videnskabelig artikel (udgivet 2014) scienca artikolo artículu científicu espublizáu en 2014 article scientifique (publié 2014) tudományos cikk 2014年论文 наукова стаття, опублікована в лютому 2014 wetenschappelijk artikel mokslinis straipsnis 2014年论文 2014年論文 научная статья мақолаи илмӣ ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek bài báo khoa học articol științific 2014年論文 artigo científico (publicado na 2014) 2014年论文 vedecký článok vitenskapelig artikkel
p:P577
wds:Q34397557-4F725CA1-3DB2-4723-85E0-DF99C78A9041
wdt:P577
2014-02-01T00:00:00Z
p:P407
wds:Q34397557-22591A10-9DD8-4285-97A8-62882867CE88
wdt:P407
wd:Q1860
p:P2860
wds:Q34397557-7E703A93-0C4D-4971-B64C-F8C3A82ECBF2 wds:Q34397557-824493E0-F0AC-41E5-80F8-E7135F67E200 wds:Q34397557-97D44ED3-3659-4892-AD22-143BF0FBB369 wds:Q34397557-4437AEB5-1ABE-4940-A06B-583B46A6AAC5 wds:Q34397557-4442973C-2916-4D67-8DEE-622C8BE178E5 wds:Q34397557-60AC1CCE-FE7A-41B9-B1E5-6A859923160C wds:Q34397557-2C0D7EC6-8AC4-44B2-B3DD-2E4997B97B96 wds:Q34397557-3AA93963-F0ED-43DF-853A-2213EC239E0D wds:Q34397557-19B4727C-17F6-44AE-B23E-A9F07C2C2C33 wds:Q34397557-20970696-0550-40A6-B172-6BBCF3F690CD wds:Q34397557-E00FCD50-5270-4115-8DB9-B8828A2EFCEE wds:Q34397557-EF2687C9-78F1-4214-89CE-E054B90A9A2A wds:Q34397557-F41C0B7A-810D-42BE-9743-9D9ABAD5FC0A wds:Q34397557-C0DC01A9-DB7C-4811-8396-AA92636EED96 wds:Q34397557-D51BFB24-90E8-4551-A3D6-23D5727DB62F wds:Q34397557-DFF3D419-737E-4AAD-B754-F904DD71A479 wds:Q34397557-760B354A-9B34-4B5C-8D12-C2853BC3CCD6 wds:Q34397557-794987C8-34AE-462F-A26A-14ABEC2664B2
wdt:P2860
wd:Q77834159 wd:Q39589974 wd:Q33232427 wd:Q24235543 wd:Q24236277 wd:Q73207851 wd:Q81066875 wd:Q37349633 wd:Q27860904 wd:Q84060424 wd:Q36675804 wd:Q52231249 wd:Q40533016 wd:Q37827340 wd:Q42911970 wd:Q40632090 wd:Q74802007 wd:Q30940394
p:P2093
wds:Q34397557-3AD50089-153B-4907-855A-0084A7067F6C wds:Q34397557-E38CA428-D9EC-4223-B2A3-1EFAAC259721 wds:Q34397557-3A43676E-D9F6-4C1E-A1E1-9DAC1BDADB2B wds:Q34397557-2126A81C-12FB-4C61-AE07-A58BB6BD0AB5 wds:Q34397557-8DB77DD0-75DA-4DFB-B5D4-DA8670060FFD wds:Q34397557-7B98843F-CF24-4922-A569-DAE961EAE9BF wds:Q34397557-6F9EB13E-956D-4276-A86A-2EEF9E512131 wds:Q34397557-5891D33F-7E2A-4977-A1CD-64D18E7646E1
wdt:P2093
Peter Dall Philipp Harter Carsten Gründker Anne Stähle Günter Emons Lars Hanker Herbert Sindermann Grigor Gorchev
rdfs:label
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Efficacy and safety of AEZS-108
skos:prefLabel
Efficacy and safety of AEZS-108 Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).
schema:name
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). Efficacy and safety of AEZS-108
p:P50
wds:Q34397557-D1C4B8D4-E3B3-4C68-B9D5-1406F2F4F666 wds:Q34397557-DB2C6AFC-3FEE-4DF8-AA25-F41F5C9A0200 wds:Q34397557-F1407E19-A67D-4145-BA0F-8802CB8974E7 wds:Q34397557-F52CF021-5179-40B2-A832-B03F8567AB96
wdt:P50
wd:Q72940290 wd:Q40942564 wd:Q124151001 wd:Q38294354
p:P1476
wds:Q34397557-395B8327-76DE-4223-A027-9F1204DEE32D
wdt:P1476
Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).
p:P304
wds:Q34397557-A9B60290-50AD-4402-911A-90E15E1CB8D6
wdt:P304
260-265
p:P31
wds:Q34397557-2849820E-4850-40C4-A8BE-E0F4F82ED284
wdt:P31
wd:Q13442814
p:P921
wds:Q34397557-41015762-41FB-46C4-B3D4-389BC8C87AED wds:Q34397557-1A0165C6-AA74-4AA9-8EBF-4DA88BDA5DC8 wds:Q34397557-033531EA-2F4A-4AB7-A890-103CD6421154 wds:Q34397557-F0DD465D-D276-4D30-8B4E-C2A2986C0BC5
wdt:P921
wd:Q6934595 wd:Q19001098 wd:Q18936 wd:Q42824440
p:P698
wds:Q34397557-261E7DB3-1B44-48F2-87D6-477E5588E54D
wdtn:P698
n11:24418927
wdt:P698
24418927
p:P1433
wds:Q34397557-E82343A6-5723-4FBF-815D-BB088C55EFDC
wdt:P1433
wd:Q15749181
p:P433
wds:Q34397557-6A13FF72-330C-4AB5-B2D2-ABD5698320A0
p:P478
wds:Q34397557-9B6D4FB2-FF23-486D-A789-45BBBE2A591B
wdt:P433
2
wdt:P478
24
p:P356
wds:Q34397557-AA8C7210-C88B-4DAB-97ED-9B8719328C11
wdtn:P356
n12:IGC.0000000000000044
wdt:P356
10.1097/IGC.0000000000000044
p:P5875
wds:Q34397557-39A2D18A-FD2A-483C-93EB-DFC8EC961E2F
wdt:P5875
259720063
p:P932
wds:Q34397557-0A7F2B07-4908-45D2-A3FC-DFACB979F072
wdt:P932
3921259